Madrigal Pharmaceuticals Inc Stock (MDGL) Forecast
The Madrigal Pharmaceuticals Inc (MDGL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $410.49, representing a +2.60% increase from the current price of $400.10. The highest analyst price target is $422.42, and the lowest is $398.56.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MDGL Price Target
Average 490.10 (+22.49% Upside)
Is Madrigal Pharmaceuticals Inc (MDGL) A Buy Now?
Oscillators
Buy: 3 · Sell: 3 · Neutral: 1Summary: Neutral
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, MDGL could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 13 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on MDGL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 23.91 indicates that MDGL is oversold. This indicates that MDGL price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 18.89 indicates that MDGL is oversold. This indicates that MDGL price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 15.61 indicates that MDGL is oversold. This suggests that MDGL price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of 33.14 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of -103.23 indicates that MDGL is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MDGL price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Madrigal Pharmaceuticals Inc financial reports and earnings history, Madrigal Pharmaceuticals Inc (MDGL) stock could reach $1,395.38 by 2030, $2,751.27 by 2040 and $3,241.50 by 2050. See the projected annual prices until 2050 of the Madrigal Pharmaceuticals Inc stock below:
- Madrigal Pharmaceuticals Inc (MDGL) is expected to reach an average price of $2,241.92 in 2035, with a high prediction of $2,265.73 and a low estimate of $1,745.96. This indicates an +460.34% change from the last recorded price of $400.10.
- Madrigal Pharmaceuticals Inc (MDGL) stock is projected to chart a bullish course in 2040, with an average price target of $2,746.64, representing an +586.49% change from its current level. The forecast ranges from a conservative $2,161.79 to a sky-high $2,751.27.
- Our analysts predict Madrigal Pharmaceuticals Inc (MDGL) to change +648.78% by 2045, soaring from $2,188.63 to an average price of $2,995.88, potentially reaching $3,005.42. While $2,188.63 is the low estimate, the potential upside is significant.
- Madrigal Pharmaceuticals Inc (MDGL) stock is expected to climb by 2050, reaching an average of $3,233.02, a +708.05% change from its current level. However, a wide range of estimates exists, with high and low targets of $3,241.50 and $2,116.14, respectively, highlighting the market's uncertainty.
Madrigal Pharmaceuticals Inc Stock (MDGL) Year by Year Forecast
Madrigal Pharmaceuticals Inc Stock (MDGL) Price Forecast for 2026
The predicted value for Madrigal Pharmaceuticals Inc (MDGL) in 2026 is set at an average of $480.25. Estimates vary from a peak of $598.79 to a trough of $353.54, indicating an +20.03% surge from the present price of $400.10.
Madrigal Pharmaceuticals Inc Stock (MDGL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Madrigal Pharmaceuticals Inc (MDGL) is $509.58, with a high forecast of $596.11 and a low forecast of $404.84. This indicates an +27.36% increase from the last price of $400.10.
Madrigal Pharmaceuticals Inc Stock (MDGL) Price Forecast for 2028
In 2028, Madrigal Pharmaceuticals Inc (MDGL) is projected to reach an average price of $850.82, with a high projection of $947.00 and a low estimate of $585.77. This indicates an +112.65% rise from the last price of $400.10.
Madrigal Pharmaceuticals Inc Stock (MDGL) Price Forecast for 2029
The 2029 price forecast for Madrigal Pharmaceuticals Inc Stock (MDGL) is $1,033.38 on average, with a high prediction of $1,179.93 and a low estimate of $844.24. This represents an +158.28% increase from the previous price of $400.10.
Madrigal Pharmaceuticals Inc Stock (MDGL) Price Forecast for 2030
Madrigal Pharmaceuticals Inc Stock (MDGL) is expected to reach an average price of $1,286.42 in 2030, with a high forecast of $1,395.38 and a low forecast of $1,128.27. This signifies an +221.53% surge from the last price of $400.10.
